|
GSK and Save the Children renew award-winning partnership, with focus on 'zero dose' children who have never received a vaccine
|
14 September 2023 |
|
New research published in Science highlights potential of a naturally occurring bacterium to help eradicate malaria
|
03 August 2023 |
|
GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health
|
19 April 2023 |
|
US FDA Advisory Committee votes to support effectiveness and safety of GSK's respiratory syncytial virus older adult vaccine candidate
|
06 March 2023 |
|
GSK announces results from 17-year retrospective study on US clinical trial diversity
|
09 February 2023 |
|
VidPrevtyn Beta COVID-19 booster vaccine, developed by Sanofi and GSK, approved for use in Great Britain
|
28 December 2022 |
|
GSK and Wave Life Sciences announce collaboration to drive discovery and development of oligonucleotide therapeutics focusing on novel genetic targets
|
13 December 2022 |
|
GSK announces positive Phase IIa study results for a new first-in-class candidate medicine for patients with tuberculosis
|
17 November 2022 |
|
GSK announces expanded collaboration with Tempus in precision medicine to accelerate R&D
|
18 October 2022 |
|
WHO grants prequalification to GSK's Mosquirix - the first and only approved malaria vaccine
|
19 September 2022 |